Managing Partner at Deerfield Management · Joined 2000
View Live Interactive Profile →Jim Flynn is Managing Partner of Deerfield Management and joined the firm in 2000. His Deerfield profile states that he is responsible for the management of the firm and that under his leadership Deerfield built its healthcare information capability through Deerfield Intelligence, expanded its investing to venture and private structured financings, established the Deerfield Foundation, created Deerfield Discovery and Development, LLC, and founded Cure, a healthcare innovation center at 345 Park Avenue South in New York City. Before Deerfield he was an analyst at Furman Selz covering pharmaceutical and medical device companies, and before that Vice President of Corporate Development at Alpharma Inc. He began his career in healthcare investing at Kidder, Peabody & Co., ultimately as a senior analyst covering the specialty pharmaceutical industry. He is a member of the Board of Trustees of the New York Academy of Medicine and of the University of Michigan Life Sciences Institute Leadership Council. In SEC filings he is identified as James E. Flynn. Deerfield reporting-group Forms 4 and Schedules 13D that carry his name are filed on behalf of the Deerfield funds as a ten percent owner and are not, on their own, evidence of a personal board seat.